This inventor holds 1 USPTO granted patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Christian Pater: Innovator in Pharmaceutical Processes
Introduction
Christian Pater is a notable inventor based in Muehlhausen-Ehingen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. Her work is characterized by a focus on creating effective treatments through advanced chemical methodologies.
Latest Patents
Christian Pater holds a patent for "Processes for preparing a pan-JAK inhibitor and related intermediate compounds." This patent outlines processes for preparing a crystalline form of a specific compound, which is crucial for the development of new therapeutic agents. The compound in question is 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile and its related intermediate compounds.
Career Highlights
Christian Pater is currently employed at Theravance Biopharma R&D IP, LLC, where she continues to advance her research in pharmaceutical processes. Her expertise in the field has led to the successful development of innovative solutions that enhance drug efficacy and safety.
Collaborations
Throughout her career, Christian has collaborated with esteemed colleagues, including Norbert Kraut and Vit Lellek. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in the pharmaceutical industry.
Conclusion
Christian Pater is a distinguished inventor whose work in pharmaceutical processes has the potential to impact the development of new therapies. Her contributions to the field exemplify the importance of innovation in improving healthcare outcomes.